» Articles » PMID: 30896985

Anxiety Sensitivity and Opioid Misuse Among Opioid-using Adults with Chronic Pain

Overview
Publisher Informa Healthcare
Specialty Psychiatry
Date 2019 Mar 22
PMID 30896985
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

: The opioid epidemic is a significant public health crisis, and this problem is particularly prevalent among individuals with chronic pain. Accordingly, there is an urgent need for interventions to mitigate the risk for opioid misuse and opioid use disorder among people with pain. Given that mental health problems, specifically anxiety, are common among people who misuse opioids, it is important to examine factors that link mental health problems with opioid misuse to ultimately inform the development of novel interventions. Anxiety sensitivity, a transdiagnostic vulnerability factor defined as the fear of anxiety-related physical sensations, may be one important mechanism in elevated opioid misuse among persons with chronic pain. : Therefore, the current cross-sectional study examined anxiety sensitivity (and construct sub-facets) as a predictor of opioid misuse among adults with chronic pain. : Adults reporting chronic pain and prescription opioid use completed an online survey. : Anxiety sensitivity was associated with multiple aspects of opioid misuse, including current opioid misuse, severity of opioid dependence, and number of opioids used to get high. The magnitude of effects ranged from medium to large. Associations between anxiety sensitivity and opioid misuse were observed over and above the variance accounted for by age, sex, income, education, perceived health, and pain severity. : These findings suggest that anxiety sensitivity may be an important treatment target among adults with chronic pain who misuse opioids. Future research should continue to explore the explanatory relevance of anxiety sensitivity in opioid misuse among individuals with chronic pain.

Citing Articles

Beliefs About Autonomic Arousal Sensations Help Explain Differences in Paraphilic Interests in Young Men and Women.

Walters L, Kane L, Shaughnessy K, Corsini-Munt S, Ouimet A, Reissing E Arch Sex Behav. 2025; 54(2):789-803.

PMID: 39812991 DOI: 10.1007/s10508-024-03060-8.


Sex differences in comorbid pain and opioid use disorder: A scoping review.

DeVito E, Ameral V, Sofuoglu M Br J Clin Pharmacol. 2024; 90(12):3067-3083.

PMID: 39168150 PMC: 11604518. DOI: 10.1111/bcp.16218.


A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders.

Nardi W, Kelly P, Roy A, Becker S, Brewer J, Sun S J Subst Use Addict Treat. 2024; 165:209442.

PMID: 38889880 PMC: 11347123. DOI: 10.1016/j.josat.2024.209442.


Indirect Effects of Negative Mood on Opioid Misuse and Dependence via Anxiety Sensitivity Subfacets: Evidence from Adults Reporting Chronic Pain.

Smit T, Mayorga N, Rogers A, Woods S, Heggeness L, Kauffman B Subst Use Misuse. 2023; 58(4):570-577.

PMID: 36762460 PMC: 10088564. DOI: 10.1080/10826084.2023.2177969.


Mind-body approaches for reducing the need for post-operative opioids: Evidence and opportunities.

Pester B, Edwards R, Martel M, Gilligan C, Meints S J Clin Anesth Intensive Care. 2023; 3(1):1-5.

PMID: 36590137 PMC: 9802583.


References
1.
Lejuez C, Zvolensky M, Daughters S, Bornovalova M, Paulson A, Tull M . Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment. Behav Res Ther. 2008; 46(7):811-8. PMC: 3175736. DOI: 10.1016/j.brat.2008.03.010. View

2.
Martel M, Finan P, McHugh R, Issa M, Edwards R, Jamison R . Day-to-day pain symptoms are only weakly associated with opioid craving among patients with chronic pain prescribed opioid therapy. Drug Alcohol Depend. 2016; 162:130-6. PMC: 4833606. DOI: 10.1016/j.drugalcdep.2016.02.047. View

3.
Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W . The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995; 90(5):607-14. DOI: 10.1046/j.1360-0443.1995.9056072.x. View

4.
Lowe B, Kroenke K, Grafe K . Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005; 58(2):163-71. DOI: 10.1016/j.jpsychores.2004.09.006. View

5.
Keough M, Schmidt N . Refinement of a brief anxiety sensitivity reduction intervention. J Consult Clin Psychol. 2012; 80(5):766-72. PMC: 3390436. DOI: 10.1037/a0027961. View